Patents by Inventor David Lyth

David Lyth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Synthesis of pyrrole acid derivatives
    Patent number: 12606524
    Abstract: This invention relates to the synthesis of compounds that can be used to treat bacterial infections in combination with other antibacterial agents, and more specifically in combination with a class of antibacterial agents known as carbapenems. The compounds resulting from the novel methods of the present invention are enzyme inhibitors and more particularly are metallo-?-lactamase inhibitors.
    Type: Grant
    Filed: October 6, 2021
    Date of Patent: April 21, 2026
    Assignee: INFEX Therapeutics Limited
    Inventors: Andrew Wilkinson, Ian Cooper, David Orr, Jonathan Finlayson, Adam Bunt, James Kirkham, David Lyth, Kevin Blades
  • ANTI-VIRAL COMPOUNDS
    Publication number: 20260078094
    Abstract: This invention relates to compounds that can be used to treat viral infections. The compounds are papain-like protease (PLpro) inhibitors.
    Type: Application
    Filed: September 13, 2023
    Publication date: March 19, 2026
    Inventors: James Kirkham, Ian Cooper, Adam Bunt, Kevin Blades, David Orr, Andrew Wilkinson, David Lyth, Oliver Smith
  • SYNTHESIS OF PYRROLE ACID DERIVATIVES
    Publication number: 20230286915
    Abstract: This invention relates to the synthesis of compounds that can be used to treat bacterial infections in combination with other antibacterial agents, and more specifically in combination with a class of antibacterial agents known as carbapenems. The compounds resulting from the novel methods of the present invention are enzyme inhibitors and more particularly are metallo-?-lactamase inhibitors.
    Type: Application
    Filed: October 6, 2021
    Publication date: September 14, 2023
    Inventors: Andrew Wilkinson, lan Cooper, David Orr, Jonathan Finlayson, Adam Bunt, James Kirkham, David Lyth, Kevin Blades
  • Antibacterial compounds
    Patent number: 10385065
    Abstract: The invention relates to antibacterial and anti-mycobacterial drug compounds of formula I. It also relates to pharmaceutical formulations of antibacterial drug compounds. It also relates to uses of the derivatives in treating bacterial infections, and methods of treating bacterial infections. The invention is also directed to antibacterial drug compounds capable of treating bacterial infections that are currently hard to treat with existing drug compounds, e.g., those caused by resistant bacterial or mycobacterial strains.
    Type: Grant
    Filed: April 10, 2015
    Date of Patent: August 20, 2019
    Assignee: Redx Pharma PLC
    Inventors: Andrew Ratcliffe, Anthony Huxley, David Lyth, Gary Noonan, Ralph Kirk, Mario Uosis-Martin, Neil Stokes
  • ANTIBACTERIAL COMPOUNDS
    Publication number: 20170158708
    Abstract: The invention relates to antibacterial and anti-mycobacterial drug compounds of formula I. It also relates to pharmaceutical formulations of antibacterial drug compounds. It also relates to uses of the derivatives in treating bacterial infections, and methods of treating bacterial infections. The invention is also directed to antibacterial drug compounds capable of treating bacterial infections that are currently hard to treat with existing drug compounds, e.g., those caused by resistant bacterial or mycobacterial strains.
    Type: Application
    Filed: April 10, 2015
    Publication date: June 8, 2017
    Applicant: Redx Pharma PLC
    Inventors: Andrew Ratcliffe, Anthony Huxley, David Lyth, Gary Noonan, Ralph Kirk, Mario Uosis-Martin, Neil Stokes